Table 4.
(A). Use of pain medication during 6-mo follow-up. (B). Additional treatment during 6-mo follow-up
| (A) All patients (n = 30) | 2 wk | 1 mo | 3 mo | 6 mo |
| Change in medication | ||||
| Less medication | 5 (22%) | 4 (20%) | 6 (33%) | 5 (40%) |
| No change | 12 (52%) | 10 (50%) | 5 (28%) | 4 (31%) |
| More medication | 6 (26%) | 6 (30%) | 7 (39%) | 4 (31%) |
| Missing | 9 | 10 | 12 | 17 |
| (B) Type of treatmenta | All patients (n = 30) | Responders (n = 9) | Chronic pancreatitis (n = 11) | Pancreatic ductal adenocarcinoma (n = 19) |
| Endoscopy | 1 (3%) | 1 (11%) | 1 (9%) | 0 |
| Surgery | 3 (10%) | 2 (22%) | 2 (18%) | 1 (5%) |
| Coeliac/splanchnic block | 5 (17%) | 0 | 1 (9%) | 4 (21%) |
| Chemotherapy | 11 (37%) | 5 (56%) | 0 | 11 (58%) |
| Radiotherapy/irreversible electroporation | 2 (7%) | 1 (11%) | 0 | 2 (11%) |
| No additional treatment | 14 (46%) | 4 (44%) | 7 (64%) | 7 (37%) |
a
Some patients had multiple (minimal) invasive treatments, e.g., chemotherapy and surgery.